Federal Agency · Food and Drug Administration
Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics
Last updated: October 23, 2026
Posted November 20, 2024
Funding
Funding amount not specified
Closes
Rolling
NAICS
541714
Food and Drug Administration — Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics Food and Drug Administration is a federal agency that offers the Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics grant program to support eligible programs and projects. This funding opportunity is available nationally and is administered by Food and Drug Administration through Grants.gov. Organizations seeking funding for eligible programs and projects should review the details below and confirm their eligibility before preparing an application. Eligibility Eligible applicants include nonprofit organizations, government agencies and municipalities, eligible organizations, and for-profit businesses. Organizations that meet the eligibility criteria are encouraged to apply and to review the full program guidelines before submission. Because eligibility rules and funding priorities can change between cycles, applicants should always confirm the current requirements with Food and Drug Administration or on Grants.gov before investing time in an application. Funding and Timeline This is a rolling or open-cycle opportunity with no fixed application deadline. Applicants should allow sufficient time to gather required documentation, including organizational information, project descriptions, budgets, and supporting materials as specified in the program guidelines. Submitting a complete application well ahead of the deadline reduces the risk of disqualification on technical or administrative grounds. Program Focus This grant supports eligible programs and projects. This grant is associated with NAICS industry classifications: 541714, 325412. Organizations operating in these sectors are encouraged to review eligibility. Funded projects are expected to demonstrate measurable outcomes aligned with the program's stated objectives. Grant recipients may be required to submit progress reports and final evaluations as a condition of the award, and to retain records for audit and compliance purposes. How to Apply Eligible organizations can apply through Grants.gov. Create a free organization profile on GrantRegister to see whether this grant matches your organization's NAICS code, entity type, location, and focus area, and to receive a weekly digest of every open grant you qualify for. GrantRegister maintains a complete, authoritative registry of US federal, state, and foundation grant opportunities — matched automatically to your organization profile and delivered every Monday.
Eligibility
- Funded by FDA
Categories
Not categorized
Sign up at GrantRegister to see if this grant matches your organization.
Match my organization →View application on Grants.gov →·Source: Grants.gov·Last seen Oct 23, 2026
Similar grants
- FY2026 Implementation of the Quagga and Zebra Mussel Action Plan (QZAP) in the Western United StatesFish and Wildlife Service · closes October 24, 2026
- Assisting Specialty Crop Exports: Low Oxygen Storage and Packaging Systems for U.S. Tree Nuts with Phytosanitary TraceabilityForeign Agricultural Service · closes October 26, 2026
- Climate Program Office (CPO) FY2026 Earth System Science and Services PartnershipDOC NOAA - ERA Production · closes October 26, 2026
- Long-term health outcomes of people living with spina bifidaCenters for Disease Control - NCBDDD · closes October 26, 2026
- ROSES25: D.8 Habitable Worlds Observatory Precursor Science InvestigationNASA Headquarters · closes October 26, 2026
- Strengthening Bosnia and Herzegovina’s Organized Crime Specialized Departments for Organized Crime Through Expert Advisory SupportU.S. Mission to Bosnia and Herzegovina · closes October 27, 2026
- OJP FY 2026 Special Attorneys Program Round 10Bureau of Justice Assistance · closes October 28, 2026
- NASA Innovative Advanced Concepts (NIAC) Phase INASA Headquarters · closes October 28, 2026
